The Faculty of Medicine announced phase-two clinical results for lipid nanoparticle carriers designed to minimize systemic side effects during chemotherapy treatment.
Patients exhibited improved tolerance alongside a 40% uptick in targeted tumor localization.
Belum ada komentar. Jadilah yang pertama!